logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rachel Galot

institut roi albert ii
H指数:10
被引数:440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab

病例报告：年轻女性尿路上皮癌伴主要鳞状分化的心脏转移：首个接受恩沃利单抗联合帕博利珠单抗治疗的病例

Frontiers in Oncology
IF3.3
2026-05-200
OA
AV Alix Vansteeger; EM El Mamoune El Ghali Benlemlih; AD Antoine Delmarche; ST Stéphane Thiry; HD Hélène Dano; JC Justine Castaigne; VP Vassiliki Pasoglou; SV Sandy Van Nieuwenhove; BG Bernhard Gerber; GA Gaby Aphram; QA Qaid Ahmed Shagera; CB Christophe Beauloye; RG Rachel Galot; CV Cédric van Marcke; ES Emmanuel Seront
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

一项关于monalizumab和durvalumab在复发性/转移性头颈鳞状细胞癌患者中的II期研究：EORTC-HNCG-1559试验（UPSTREAM）中I2组的成果

ESMO OPEN
IF8.3
2025-05-010
OAAI
Galot, R.; Le Tourneau, C.; Licitra, L.; Guigay, J.; Kong, A.; Tinhofer, I.; Even, C.; Daste, A.; Henry, S.; Borel, C.; Abdeddaim, C.; Seront, E.; Prevost, J. B.; Rutten, A.; Saada-Bouzid, E.; Rolland, F.; Bonomo, P.; Rasschaert, M.; Dirix, L.; Olungu, C.; Tsechilidou, K.; Govaerts, A. S.; Fortpied, C.; Joaquim, A.; Machiels, J. P.
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma

新型溴结构域和-extra-terminal结构域抑制剂BI 894999在晚期实体瘤或弥漫性大B细胞淋巴瘤患者中的Ia/Ib期研究最终结果

ESMO OPEN
IF8.3
2025-05-010
PRE
Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; Rottey, S.; Sadrolhefazi, B.; Marzin, K.; Musa, H.; Schoffski, P.
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor

循环肿瘤DNA的肿瘤不可知血浆测定可预测用PD-1抑制剂治疗的头颈部复发和/或转移性鳞状细胞癌的结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-12-010
PRE
Honore, Natasha; van der Elst, Athenais; Dietz, Anna; van Marcke, Cedric; Helaers, Raphael; Mendola, Antonella; Dahou, Hajar; Marbaix, Etienne; Poncin, Renaud; Seront, Emanuel; Schmitz, Sandra; Limaye, Nisha; Galot, Rachel; Machiels, Jean-Pascal
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

循环肿瘤DNA的肿瘤不可知血浆测定可检测微小残留疾病并预测头颈部局部晚期鳞状细胞癌的预后

ANNALS OF ONCOLOGY
IF65.4
2023-12-0115
OA
Honore, N.; van Marcke, C.; Galot, R.; Helaers, R.; Ambroise, J.; van Maanen, A.; Mendola, A.; Dahou, H.; Marbaix, E.; Van Eeckhout, P.; Longton, E.; Magremanne, M.; Schmitz, S.; Limaye, N.; Machiels, J. -P.
Preclinical and emerging Phase 1 study data indicates that novel deuterated MET kinase inhibitor DO-2 mitigates the side effects seen with current approved MET kinase inhibitors: Preventing deleterious ′de-hinging′ to improve tolerability
MOLECULAR CANCER THERAPEUTICS
IF5.5
2023-12-010
PRE
Perera, Timothy P. S.; Mevellec, Laurence; Prenen, Hans; Dekeyser, Bernd; Robbrecht, Debbie; Bins, Sander; Sikkema, Barend; de Bruijn, Peter; Machiels, Jean-Pascal; Galot, Rachel; Briol, Damien; Knight, Richard; Loryan, Irena; Hu, Yang; Wastelin, Florence; Verweij, Jaap
Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Honore, N.; de Lummen, C. Van Marcke; Galot, R.; Helaers, R.; van Maanen, A.; Ambroise, J.; Mendola, A.; Dahou, H.; Marbaix, E.; Van Eeckhout, P.; Longton, E.; Magremanne, M.; Schmitz, S.; Limaye, N.; Machiels, J-P.
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
OA
Galot, R.; Le Tourneau, C.; Licitra, L. F. L.; Even, C.; Daste, A.; Henry, S.; Borel, C.; Abdeddaim, C.; Seront, E.; Prevost, J. B.; Rutten, A.; Saada, E. B.; Rolland, F.; Livi, L.; Specenier, P. M. C.; Leys, J.; Olungu, C.; Lefevre, C. Fortpied; Joaquim, A.; Machiels, J-P.
Safety and anti-tumor activity of a novel Treg depleter RG6292, as a single agent and in combination with atezolizumab in patients with solid tumors
CANCER RESEARCH
IF16.6
2023-04-142
PRE
Gambardella, Valentina; Ong, Michael; Ruiz, Maria Esperanza Rodriguez; Machiels, Jean-Pascal; de Sanmamed, Miguel Fernandez; Tabernero, Josep Maria; Spreafico, Anna; Renouf, Daniel J.; Luen, Stephen J.; Galot, Rachel; Uribe, Bernard Doger de Speville; Aller, Emiliano Calvo; Naing, Aung; Curdt, Samira; Rossmann, Eva; Tanos, Tamara; Smart, Kevin; Amann, Maria; Xie, Yuying; Schnetzler, Gabriel; Boetsch, Christophe; Karanikas, Vaios; Kolben, Theresa; Xu, Linxinyu; Rohrberg, Kristoffer S.
Pharmacokinetic/pharmacodynami c (PK/PD) relationships of the novel Treg depleter RG6292 in Phase Ia and Ib studies in patients with solid tumors
CANCER RESEARCH
IF16.6
2023-04-142
PRE
Tanos, Tamara; Smart, Kevin; Gambardella, Valentina; Rohrberg, Kristoffer; Ong, Michael; Ruiz, Maria Esperanza Rodriguez; Machiels, Jean-Pascal; Sanmamed, Miguel Fernandez; Tabernero, Josep; Spreafico, Anna; Renouf, Daniel; Luen, Stephen; Galot, Rachel; Doger, Bernard; Calvo, Emiliano; Naing, Aung; Curdt, Samira; Staedler, Nicolas; Flores, Mike; Alcaide, Enrique Gomez; Ooi, Chiahuey; Hettich, Michael; Dziadek, Sebastian; Xie, Yuying; Schnetzler, Gabriel; Kolben, Theresa; Xu, Linxinyu; Karanikas, Vaios; Boetsch, Christophe
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2021-11-0145
PREAI
Galot, Rachel; Le Tourneau, Christophe; Saada-Bouzid, Esma; Daste, Amaury; Even, Caroline; Debruyne, Philip; Henry, Stephanie; Zanetta, Sylvie; Rutten, Anemie; Licitra, Lisa; Canon, Jean-Luc; Kaminsky, Marie-Christine; Specenier, Pol; Rottey, Sylvie; Guigay, Joel; Kong, Anthony; Tinhofer, Inge; Borcoman, Edith; Dirix, Lieve; Raveloarivahy, Tiana; Fortpied, Catherine; Vanlancker, Maureen; Morfouace, Marie; Govaerts, Anne-Sophie; Machiels, Jean-Pascal
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study
BMC CANCER
IF3.4
2021-05-209
OAAI
van Marcke, C.; Honore, N.; van der Elst, A.; Beyaert, S.; Derouane, F.; Dumont, C.; Aboubakar Nana, F.; Baurain, J. F.; Borbath, I.; Collard, P.; Cornelis, F.; De Cuyper, A.; Duhoux, F. P.; Filleul, B.; Galot, R.; Gizzi, M.; Mazzeo, F.; Pieters, T.; Seront, E.; Sinapi, I.; Van den Eynde, M.; Whenham, N.; Yombi, J. C.; Scohy, A.; van Maanen, A.; Machiels, J. P.

研究方向

暂未获取到该数据
C
Cédric van Marcke
H 指数:17论文数:80被引数:868
J
Jean‐Pascal Machiels
H 指数:39论文数:412被引数:5,694
N
Natasha Honoré
H 指数:6论文数:21被引数:161
E
Emmanuel Seront
H 指数:22论文数:149被引数:2,387
H
Hajar Dahou
H 指数:7论文数:29被引数:148
J
J-P. Machiels
H 指数:19论文数:135被引数:1,878
C
Christophe Le Tourneau
H 指数:67论文数:631被引数:2.2万
L
Lisa Licitra
H 指数:86论文数:920被引数:4.0万
R
Raphaël Helaers
H 指数:21论文数:76被引数:2,163
S
Sylvie Rottey
H 指数:50论文数:570被引数:1.2万